Bristol-Myers Squibb to Pay $20M in Abilify Settlement
Abilify manufacturer, Bristol-Myers Squibb has reached a nearly $20 million Abilify settlement. This Abilify settlement is with 42 U.S. states and the District of Columbia after accusations the company improperly marketed the blockbuster antipsychotic drug Abilify (aripiprazole). The court found that Bristol-Myers Squibb unlawfully marketed Abilify to seniors with dementia and Alzheimer’s diseases. This is even though
Read More
Thirty Percent of Hernia Surgeries Could Have Used Faulty Hernia Mesh
Every year, 1 million people have their hernia repaired. They trust their doctors that this surgery is necessary for them to relieve their constant pain. Now, many are finding the hernia mesh used in their surgeries were rushed to market and is causing more damage than their hernia ever did. Thirty percent of hernia surgeries
Read More
Johnson & Johnson and Their Dangerous Legacy
For decades, Johnson & Johnson created a wholesome brand to appeal to the American consumer. They have tricked people into thinking their products are safe. However, more and more of their products are failing. Failing so gravely that serious harm is befalling those same innocent consumers who trusted their wholesome image. This is Michael Brady
Read More
Ethicon’s Physiomesh Flexible Composite Mesh Recall
Johnson & Johnson’s manufacturer, Ethicon issued a full recall of its Physiomesh Flexible Composite Mesh after two studies found higher rates of hernias re-opening versus similar products. What is Physiomesh Flexible Composite Mesh? Every year, surgeons perform around 150,000 ventral hernia repairs in the United States. Doctors can perform the operation laparoscopically or by opening
Read More
Ovarian Cancer Misdiagnosis Grow Along with Talcum Powder Lawsuits
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. The Daily Mail recently reported doctors misdiagnose almost half of women with ovarian cancer. This mean to 4 in 10 patients with cancer did not have their symptoms taken seriously. Therefore, doctors did not perform the necessary ovarian cancer screenings for
Read More
Xarelto May Cause Dementia in AFib Patients
This is Michael Brady Lynch, Lead Trial Attorney for the Michael Brady Lynch Firm. Researchers at the Intermountain Medical Center Heart Institute published a study warning people with the heart rhythm disorder atrial fibrillation (AFib) that they may have a heightened risk of developing dementia while taking clot-preventing drugs like Xarelto. The study researched over 6,000
Read MoreAttorney Michael Brady Lynch Appointed to Plaintiff’s Executive Committee in Pradaxa Litigation
On November 18, 2016, Judge Mary Wiss appointed Michael Brady Lynch, Lead Trial attorney and founder of The Michael Brady Lynch Firm to serve on the Plaintiff’s Executive Committee (PEC) in Pradaxa litigation JCCP 4863. Attorneys across the country have continually asked Attorney Michael Brady Lynch to step into leadership positions for many litigations. Lynch
Read More
FDA Updates Essure’s Warning Label Instead of Recall
After treating women as though their injuries were invalid, the FDA is finally asking Bayer, the manufacturer of Essure, to update the warning label on the dangerous permanent birth control, Essure. The new label will include warnings for the risk of implant perforation, device migration, allergic reaction, pain and other possible adverse events. The Essure
Read More
Stryker Hip Implant: The Silent Killer
This is Michael Brady Lynch, Lead Trial Attorney, for The Michael Brady Lynch Firm. Imagine going through a painful hip replacement surgery only to find out that within a few months or even a few short years, your implant is slowly killing you. Many are facing this grim reality. They are realizing the metal implant
Read MoreThe Dangers of Generic Viagra
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. Next year, manufacturer Teva will release a generic version of the popular erectile dysfunction medication, Viagra. This will be the first time a generic form of the drug will be released in The United States. The FDA approved three different strengths of the
Read More